(VIANEWS) - Newell Rubbermaid (NWL), Royalty Pharma (RPRX), Abbott Laboratories (ABT) are the highest payout ratio stocks on this list.
Here's the data we've collected of stocks with a high payout ratio as yet. The payout ratio in itself isn't a promise of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Newell Rubbermaid (NWL)
54.76% Payout Ratio
Newell Brands Inc. manufactures, sources and distributes commercial and consumer products around the world.
Volume
Today's last reported volume for Newell Rubbermaid is 3054820, 3.7% below its average volume of 3172370.
As stated by Morningstar, Inc., the next dividend payment is on May 26, 2022, the estimated forward annual dividend rate is 0.92 and the estimated forward annual dividend yield is 4.05%.
Newell Rubbermaid's sales growth this year is anticipated to be negative 4% and 1.4% for next year.
Year-on-year quarterly revenue growth grew by 4.4%, now sitting on 10.69B for the twelve trailing months.
Newell Rubbermaid's sales growth is 0.9% for the current quarter and negative 6.3% for the next. The company's growth estimates for the ongoing quarter and the next is negative 16.1% and 7.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.29%.
Volatility
Newell Rubbermaid's last day, week, and month's current intraday variation average was 3.16%, 4.04%, and 3.61%, respectively.
Newell Rubbermaid's highest amplitude of average volatility was 5.29% (day), 5.35% (last week), and 5.19% (last month), respectively.
Newell Rubbermaid's Stock Yearly Top and Bottom Value
Newell Rubbermaid's stock is valued at $21.88 at 14:23 EST, way under its 52-week high of $29.10 and way above its 52-week low of $18.67.
Newell Rubbermaid's Moving Average
Newell Rubbermaid's value is below its 50-day moving average of $22.12 and under its 200-day moving average of $23.03.2. Royalty Pharma (RPRX)
48.95% Payout Ratio
Royalty Pharma plc is a purchaser of biopharmaceutical royalty payments and a financier of innovation in the US biopharmaceutical sector.
Volume
Today's last reported volume for Royalty Pharma is 548053, 74.59% below its average volume of 2157610.
According to Morningstar, Inc., the next dividend payment is on May 18, 2022, the estimated forward annual dividend rate is 0.76 and the estimated forward annual dividend yield is 1.95%.
Royalty Pharma's sales growth this year is expected to be negative 1% and 7.8% for next year.
Year-on-year quarterly revenue growth grew by 0.6%, now sitting on 2.29B for the twelve trailing months.
Royalty Pharma's sales growth is 0.4% for the ongoing quarter and negative 0.5% for the next. The company's growth estimates for the present quarter and the next is 11.3% and negative -5.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.32%.
Volatility
Royalty Pharma's last day, week, and month's current intraday variation average was 0.10%, 1.00%, and 1.31%, respectively.
Royalty Pharma's highest amplitude of average volatility was 1.47% (day), 2.22% (last week), and 2.73% (last month), respectively.
Royalty Pharma's Stock Yearly Top and Bottom Value
Royalty Pharma's stock is valued at $40.36 at 14:23 EST, way below its 52-week high of $47.10 and way above its 52-week low of $34.86.
Royalty Pharma's Moving Average
Royalty Pharma's value is under its 50-day moving average of $40.84 and higher than its 200-day moving average of $39.39.3. Abbott Laboratories (ABT)
42.43% Payout Ratio
Abbott Laboratories develops and manufactures products for health worldwide.
Volume
Today's last reported volume for Abbott Laboratories is 2025570, 62.46% below its average volume of 5396100.
As maintained by Morningstar, Inc., the next dividend payment is on Oct 13, 2021, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 1.39%.
Abbott Laboratories's sales growth this year is anticipated to be 15.1% and a negative 1.4% for next year.
Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 42.31B for the twelve trailing months.
Abbott Laboratories's sales growth is 6.7% for the ongoing quarter and negative 9.3% for the next. The company's growth estimates for the ongoing quarter and the next is negative 5.1% and negative -30.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.86%.
Volatility
Abbott Laboratories's last day, week, and month's current intraday variation average was 0.81%, 1.58%, and 1.28%, respectively.
Abbott Laboratories's highest amplitude of average volatility was 1.05% (day), 2.57% (last week), and 2.41% (last month), respectively.
Abbott Laboratories's Stock Yearly Top and Bottom Value
Abbott Laboratories's stock is valued at $116.82 at 14:23 EST, way below its 52-week high of $134.50 and way above its 52-week low of $105.36.
Abbott Laboratories's Moving Average
Abbott Laboratories's worth is below its 50-day moving average of $125.22 and below its 200-day moving average of $121.01.4. Atrion (ATRI)
40.71% Payout Ratio
Atrion Corporation designs, manufactures and markets products for fluid delivery and cardiovascular applications.
Volume
Today's last reported volume for Atrion is 222, 94.27% below its average volume of 3876.
As maintained by Morningstar, Inc., the next dividend payment is on Mar 13, 2022, the estimated forward annual dividend rate is 7.8 and the estimated forward annual dividend yield is 1.27%.
Year-on-year quarterly revenue growth grew by 25%, now sitting on 165.01M for the twelve trailing months.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.64%.
Volatility
Atrion's last day, week, and month's current intraday variation average was 3.27%, 1.21%, and 1.31%, respectively.
Atrion's highest amplitude of average volatility was 2.48% (day), 2.12% (last week), and 2.07% (last month), respectively.
Atrion's Stock Yearly Top and Bottom Value
Atrion's stock is valued at $620.00 at 14:23 EST, way below its 52-week high of $805.62 and above its 52-week low of $579.96.